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Background: In Cameroon herbs are traditionally used to meet health care needs and plans are on the way to
integrate traditional medicine in the health care system, even though the plans have not been put into action yet.
The country however has a rich biodiversity, with ~8,620 plant species, some of which are commonly used in the
treatment of several microbial infections and a range of diseases (malaria, trypanosomiasis, leishmaniasis, diabetes
and tuberculosis).
Methods: Our survey consisted in collecting published data from the literature sources, mainly from PhD theses in
Cameroonian university libraries and also using the author queries in major natural product and medicinal
chemistry journals. The collected data includes plant sources, uses of plant material in traditional medicine, plant
families, region of collection of plant material, isolated metabolites and type (e.g. flavonoid, terpenoid, etc.),
measured biological activities of isolated compounds, and any comments on significance of isolated metabolites on
the chemotaxonomic classification of the plant species. This data was compiled on a excel sheet and analysed.
Results: In this study, a literature survey led to the collection of data on 2,700 secondary metabolites, which have
been previously isolated or derived from Cameroonian medicinal plants. This represents distinct phytochemicals
derived from 312 plant species belonging to 67 plant families. The plant species are investigated in terms of
chemical composition with respect to the various plant families. A correlation between the known biological
activities of isolated compounds and the ethnobotanical uses of the plants is also attempted. Insight into future
direction for natural product search within the Cameroonian forest and Savanna is provided.
Conclusions: It can be verified that a phytochemical search of active secondary metabolites, which is inspired by
knowledge from the ethnobotanical uses of medicinal plants could be very vital in a drug discovery program from
plant-derived bioactive compounds.
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The African continent holds an enormous resource in
terms of floral biodiversity and its medicinal plants
have remained a main reservoir of phytochemicals for
pharmaceutical drug development [1,2]. The above
argument could be strengthened by the fact that the* Correspondence: ntiekfidele@gmail.com
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reproduction in any medium, provided the orlocal populations, especially South of the Sahara, have
depended on medicinal plants as the main source of
remedy for the treatment of several medical disorders over
the past centuries [3]. The World Health Organization
(WHO) defines traditional medicine as practices, knowledge
and belief systems which use minerals, plants and
animal based remedies, spiritual therapies and exercises to
prevent, treat and maintain well being [4]. According to
WHO, 80% of the world’s population used natural remedies
and traditional medicines [4,5]. This is particularly the
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to traditional medicine for their primary health care.
Despite the advances in Western medicine (WM), African
traditional medicine (ATM) has gained renewed interest
in the health care services throughout the continent. This
has probably been motivated by the rapidly increasing
awareness of the potential and curative abilities of alterna-
tive medicines, especially from the use of medicinal plants,
as well as the inadequate access to WM and physicians
and the high cost for Western drugs [6]. ATM utilises
medicinal plants which are traditionally taken as concoc-
tions and infusions [7]. The argument for the local African
populations resorting to traditional remedies could also be
partly justified by the fact that natural product inspired
molecules represented 80% of drugs that had been put
into the drug market by 1990 [8-10]. The above figures
have been the motivating factor behind the efforts of
several research teams spread across the African continent,
which have been actively engaged in an ethnobotanical/
bioassay-guided search for active principles from medicinal
plants which have been employed in ATM. The aim has
been to extract, isolate and structurally characterise plant
metabolites which could be developed into modern thera-
peutic agents. This process has often been coupled with
biological screening of the isolated compounds, with a
view to validating the uses of the plants in traditional
medicine, thus identifying the molecular structures that
could be further developed into drugs. Very often, success
in this endeavour could be attributed to the closeness of
the collaboration between experts in various fields like
traditional healers, ethnobotanists, plant taxonomists,
phytochemists, and biochemical screeners [11]. Since ATM
often employs the preparation of macerations, preparation
of decoctions of stem barks, leaves and roots, burning of
leaves and using the derived ashes, etc., a rather straight-
forward procedure could be to test for the activity of the
crude extracts of these plant parts. Such research has been
reported and the results for activity as well as the toxicity
of crude extracts serve as a guide towards the development
of “total” extracts which are often directly conditioned and
used in the low cost “modern” traditional treatments,
affordable to the local populations [12]. Such approaches
could however present serious drawbacks when situated
within a modern context of WM. In WM, modern
pharmaceutical companies have elaborated expensive
Research and Development (R&D) procedures that work
with highly sophisticated solid support combinatorial
synthesis followed by highthroughput screening (HTS),
in vivo animal model evaluations and clinical trials in
order to determine appropriate doses, modes of adminis-
tration and possible side effects before marketing the
finished products (drugs). It could however be noted that
one of the strongest arguments why ATM has become the
main stay in the health care system of the continent,despite the above mentioned drawbacks, is that its local
populations are often incapable of purchasing the expensive
Western drugs [13].
In Cameroon, located in the core of the continent, and
bounded by Nigeria (to the West), Chad (to the North
and North East), Central Africa Republic to the South
East and Gabon, Congo and Equatorial Guinea to the
South (Figure 1), the picture is not very different from
what is seen throughout the rest of the continent. The
mortality patterns reflect high levels of infectious diseases
and the risk of death during pregnancy and childbirth, in
addition to cancers, cardiovascular diseases and chronic
respiratory diseases which account for most deaths in the
developed countries [14]. It has been reported that only 3
out of 20 patients are able to buy prescribed drugs in
hospitals and only 1 out of every 1000 patients is able to
consult a specialist [15]. As a result there is a rich tradition
in the use of herbal medicines for the treatment of several
ailments and plans are on the way to integrate traditional
medicine in the health care system, even though the plans
have not been put into action yet [16]. Cameroon however
has a rich biodiversity, with ~8,620 plant species [17,18],
some of which are commonly used in the treatment of
several microbial infections [19] and a range of neglected
tropical diseases, including malaria, trypanosomiasis, leish-
maniasis, diabetes, tuberculosis, etc. [15]. Adjanohoun et al.
have provided a useful review on a collection of 414 plants
used in traditional medicine in Cameroon, belonging to
95 plant families [20]. However, in addition to the fact that
the formulations of the plant materials to be used as drugs
in ATM have not been validated in a well documented
and universally accepted pharmacopoeia, no details are
given regarding the chemical composition of these plants.
Jiofack et al. added to this by providing the formulation
for 289 plant species belonging to 89 families, which have
been used in two ethnoecological regions (Littoral-South
West, and Sudano-Sahelian regions) of Cameroon for
the treatment of various ailments, including amoebiasis,
boils, cough, dermatitis, diarrhoea, dysentery, fever, gastri-
tis, gonorrhoea, malaria, male sexual disorders, ovarian
cysts, rheumatism, sexually transmitted diseases, sterility,
syphilis, typhoid, and wounds [21-23]. Jiofack et al. also
added a list of 140 plant species belonging to 60 families,
which are used to treat a wide range of ailments in the
upper Nyong valley forest in Cameroon [24]. Simbo also
carried out an ethnobotanical survey around Babungo in
the North West region of Cameroon, in which 107 plant
species from 54 plant families (mostly from the
Asteraceae family), used for the treatment of 55 health
problems, were identified [25], while Focho et al. iden-
tified 82 species of trees belonging to 70 genera and 42
families used by the local people in traditional medicine
around Fundong in the North West region to treat 48 hu-
man ailments [26]. Ngono et al. carried out a survey in
Figure 1 Cameroon (in brown) and its surrounding neighbours.
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Centre and South regions were identified [7]. Noumi et al.
identified 26 plant species used to treat hypertension in
the Bafia area of the Centre region [27], 22 medicinal
plant species used in the treatment of urinary lithiasis in
the Littoral region [28], 29 plants from 24 families used in
the treatment of asthma in the Nkongsamba region [29],
29 medicinal plants used in the treatment of peptic ulcers
around Bagangte in the West region [30], as well as 50
plants from 33 families which are used in the treatment of
syphilis in Ebolowa in the South region, Cameroon [31].
Mpondo et al. conducted an ethnobotanical survey among
the Douala communities and identified more than 100
genera which have been used in the treatment of diverse
diseases like stomach ache, tooth ache, diabetes, cough,
yellow fever, amoebic dysentery, anaemia, intestinal worms,
fever and diarrhoea [32-38]. Ngo Bum et al. also reported
23 plants species used in Cameroon and Central Africa to
treat epilepsy [39], while Betti identified 102 plants from 97
genera and 51 families used mainly to treat cough, lacta-
tion failure, malaria, wounds, and toothache among the
Baka Pygmies in the Dja biosphere reserve [40]. Sandberg
et al. have also reported a collection of 32 botanically
identified medicinal plants from the Mount Cameroon
slope, made by Swedish settlers at the beginning of the last
century, which has been donated to the Karolinska
Institutet, Sweden [41]. In all the above cases, no details
were given about the active principles contained in these
plants, which render them useful in ATM. Titanji et al.have however previously presented a review of about 217
cited species used in the treatment of malaria in
Cameroon, among which about 100 potential leads for the
development of new antimalarials had been isolated from
26 species [42].
In a recent paper, we have reported the results of a
survey of the chemical composition of 234 plant species
(representing 55 families) from the Cameroonian rainfor-
est, from which 1,859 distinct compounds had been iso-
lated or derived [43]. Our focus had been to highlight the
medicinal value and virtues of the isolated phytochemicals
by discussing the various measured biological activities and
evaluating the “drug-like” properties by use of Lipinski’s
“Rule of Five” [44]. In the current paper, we have enriched
the data collection to include phytochemicals from 312
distinct plant species from 67 families, for which biological
activities of 46.3% of the 2,769 pure compounds have been
determined, and among which 32.7% of the compounds
were identified or derived from Cameroonian medicinal
plants for the very first time. In addition, we present and
discuss 98 compounds whose measured biological activities
correlated well with the ethnobotanical uses of the plants
in ATM. An attempt to relate the chemical composition of
the plant species to the families and genera is also carried
out. From our study, it can be verified that a phytochemical
search of active secondary metabolites, which is inspired
by knowledge from the ethnobotanical uses of medicinal
plants could be very vital in a drug discovery program from
plant-derived bioactive compounds.
Figure 2 Bar chart showing the distribution of isolated
compounds by plant family. Family names are indicated by the
first four letters, e.g., Apoc = Apocynaceae.
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Data sources and collection methods
The plant sources, geographical collection sites, chemical
structures of pure compounds as well as their spectroscopic
data, were retrieved from literature sources comprising
of data collected from 30 PhD theses, 556 articles from 75
peer reviewed journals, 7 unpublished conference presen-
tations (from personal communication with the authors)
and 2 textbook chapters, spanning the period 1971 to
2013. A full list of journals consulted is given in the sup-
plementary material (Additional file 1). Our survey
consisted in collecting published data from the literature
sources, mainly from PhD theses in Cameroonian univer-
sity libraries and also using the author queries in major
natural product and medicinal chemistry journals. The col-
lected data includes plant sources, uses of plant material in
traditional medicine, plant families, region of collection of
plant material, isolated metabolites and type (e.g. flavonoid,
terpenoid, etc.), measured biological activities of isolated
compounds, and any comments on significance of isolated
metabolites on the chemotaxonomic classification of the
plant species (as commented in the literature). This data
was compiled on a excel sheet and analysed.
Results and discussion
Chemotaxonomy of Cameroonian medicinal plants
Chemotaxonomy or chemosystematics is the attempt to
classify and identify organisms (originally plants), according
to demonstrable differences and similarities in their bio-
chemical compositions. Generally speaking, it has been
observed that plants of the same family usually synthesize
compounds of similar classes due to the presence of similar
classes of enzymes and hence similar biosynthetic pathways.
Moreover, the medicinal plants surveyed are a complex of
species from different groups (genera or families). This
paper is not intended to give an accurate description of the
chemotaxonomy of Cameroonian medicinal plants. The
similarities or differences of chemical components from
different medicinal plants presented herein are solely based
on data published so far, by presenting trends towards the
full description of the taxonomy of the studied families and
species.
Our initial collection was composed of 3,742 phytochem-
icals previously isolated from 67 families, along with 319 of
some of their hemisynthetic products, giving a total of 4061
chemical structures. Removal of duplicates gave 2,770 pure
compounds. In our analyses, emphasis was laid on those
plant families from which at least 2.5% of the secondary
metabolites have been isolated. These include, by order
of merit, Leguminosae (13.9%), Moraceae (10.6%), Guttiferae
(10.1%), Rutaceae (6.5%), Meliaceae (4.5%), Euphorbiaceae
(4.4%), Compositae (3.9%), Zingiberaceae (3.4%), Ochnaceae
(3.2%), Bignioniaceae (3.1%), Sapotaceae (3.1%) and
Apocynaceae (2.8%), Figure 2. An overall distribution bycompound type (based solely on unique compounds, not
compound concentrations in the plants) is shown in
Figure 3. This revealed that terpenoids were most abundant
in Cameroonian medicinal plants (constituting 26.0% of
the isolated compounds). This was followed by flavonoids
(19.6%), alkaloids (11.8%), xanthones (5.4%), quinones
(5.0%) and glycosides (4.9%), showing a similar trend
with our previous analysis of 1,859 metabolites [43].
A more detailed analysis of compounds isolated per
family is given in Table 1. From the Leguminosae family, it
was shown that most of the isolated metabolites were
flavonoids (68.3%). A similar trend was seen in the
Ochnaceae and Moraceae families with respective flavon-
oid % compositions of 69.2% and 39.7%. The terpenoid rich
families are the Meliaceae (74.4%), the Euphorbiaceae
(68.5%), the Sapotaceae (43.2%) and the Zingiberaceae
(70.1%), while the alkaloid rich families are the
Apocynaceae (54.4%) and the Rutaceae (54.6%). From
our analyses it was shown that, as in our previous paper,
most of the isolated metabolites from the Guttiferae family
were xanthones and quinines [43]. Moreover, within the
Leguminosae family, isoflavonoids and diterpenoids, with
insecticidal, piscicidal, and molluscicidal properties, are
taxonomic markers of the genus Millettia [45]. Meanwhile
within the Bignoniaceae family, sterequinone F (1), ursolic
acid (2), triacontan-1,30-dioldiferulate (3) and p-coumaric
acid (4) have been identified as the taxonomic markers for
the genus Stereospermum, while the glycoside eutigoside
A (5) has been used to differentiate S. accuminatissimum
from other members of the genus [46-48]. The chemical
structures of the taxonomic markers are shown in Figure 4.
Within the Guttiferae family, laurentixanthone C (6)
Figure 3 Pie chart showing the distribution by compound types.
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genus Vismia [49]. As for the Moraceae family, the cou-
marins psoralen, bergapten, 7-hydroxycoumarin and 7-
methoxycoumarin (7 – 10 respectively) and lupeol (11)
have been identified as taxonomic markers for theTable 1 Summary of the chemical composition of the remarkab
Plant family % of isolated compounds Remarkable compound cla
(% composition)
Apocynaceae 2.8 Alkaloids (54.4%)
Bignoniaceae 3.1 Quinones (26.3%)
Compositae 3.9 Terpenoids (54.1%)
Euphorbiaceae 4.4 Terpenoids (68.5%)
Guttiferae 10.1 Xanthones (37.5%), Quinone
Leguminosae 13.9 Flavonoids (68.3%)
Meliaceae 4.5 Terpenoids (74.4%)
Moraceae 10.6 Flavonoids (39.7%)
Ochnaceae 3.2 Flavonoids (69.2%)
Rutaceae 6.5 Alkaloids (54.6%)
Sapotaceae 3.1 Terpenoids (43.2%)
Zingiberaceae 3.4 Terpenoids (70.1%)Dorstenia genus [50]. It was however generally observed
that species of the genus Dorstenia harvested from
across the African continent are particularly unique in
that they produce a wide range of chalcones and
bichalcones, prenylated flavonols, benzofuran derivatives,le plant families with abundant phytochemicals isolated
sses Genera studied
Holarrhena, Picralima, Tabernathe, Voacanga, Picralima,
Rauvolfia and Plumeria
Kigelia, Newbouldia, Spathodea and Stereospermum
Chromoleana, Crassocephalum, Crepis, Echinops,
Elephantopus, Eupatroium, Helichrysum, Microglossa,
Senecio, Tithonia and Vernonia
Alchornea, Antidesma, Croton, Discoglypremna, Drypetes,
Fontainea, Macaranga, Maesobotrya, Neoboutonia,
Thecacoris and Uapaca
s (26.3%) Allanblackia, Calophyllum, Endodesmia, Garcinia, Harungana,
Hypericum, Pentadesma, Psorospermum, Symphonia and Vismia
Cassia, Crotalaria, Eriosema, Erythrina, Guibourtia, Millettia,
Tephrosia and Piptadenia
Carapa, Entandrophragma, Leplaea, Pterorhachis, Synsepalum,
Trichilia and Turraeanthus
Antiaris, Artocarpus, Dorstenia, Ficus, Melicia, Milicia, Morus,
Treculia and Trilepisium
Campylospermum, Lophira, Ochna and Ouratea
Afraegle, Araliopsis, Basalmocitrus, Citropsis, Clausena, Fagara,
Oricia, Oriciopsis, Teclea, Vepris, and Zanthoxylum



































































































































Figure 4 Chemical structures of taxonomic markers.
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Table 2 Summary of ethnobotanical uses versus measured biological activities of isolated secondary metabolites








The aerial part of this plant
is used in the treatment of
various microbial infections,
such as skin diseases and
infections of the urinary tract.
aerial parts 11, 24, 25
and 26
Antimicrobial,
Tamokou et al. [73]
Amaryllidaceae Crinum
purpurascens
The macerated leaves are used
as anti-poison or as antidote of
mystical poisoning. Also, an
infusion of the leaves is used for
the treatment of some microbial
infections.
leaves 27 and 28 Anti-salmonellal and antibacterial,
Nkanwen et al. [74]
Asteraceae Senecio mannii The plant is used to treat microbial
and fungal infections.
aerial parts 29 and 30 Antifungal, Ndom et al. [75]
Bignoniaceae Stereospermum
zenkeri
The bark is to treat bronchitis; its
roots and leaves are used to cure
fever and microbial infections.
stem bark 31 and 32 Antimicrobial, Lenta et al. [48]
Bombacaceae Ceiba pentandra The plant is well reputed in for the
treatment of many illnesses, such
as, headache, dizziness, constipation,
skin diseases, mental troubles,
and fever.
stem bark 33 and 34 Antifungal, Ngounou et al. [76]
Caesalpiniaceae Cassia petersiana The leaves are generally used for
the treatment of typhoid fever.
leaves 35, 36, 37, 38,
39 and 40
Antisalmonellal activity,
Djemgou et al. [77],
Gatsing et al. [78]
Combretaceae Pteleopsis
hylodendron
Treatment of STDs, female sterility,
kidney and liver disorders and
dropsy.
bark 41, 42, 43
and 44
Active against Staphylococcus
aureus, S. pyogenes, and Baccilus
cereus, Rahman et al. [79]
Terminalia superba Used to treat gastroenteritis,
diabetes, female infertility and
abdominal pain.
bark 45 and 46 α-Glycosidase inhibition,
immunoinhibitory activity,
Tabopda et al. [80]
Ebenaceae Diospyros
canaliculata
Used in the treatment of whooping
cough, leprosy, snake bites, scabies,
skin eruptions, dysentery, eye
infections, menstrual troubles,
abdominal pains, wounds, ulcers,
chest pains and skin infections.
stem bark 11, 47 and 48 Antifungal activity,





Used to treat several ailments
including malaria, skin infections,
venereal diseases, gastrointestinal
disorders, tumours, and infertility,
epilepsies and nerves problems.
stem bark 49, 50, 51
and 52
Anti-malarial,
Zofou et al. [62]
Harungana
madagascariensis
Effective in the treatment of
jaundice, diarrhoea, dysentery,
typhoid fever, and constipation.
Decoction of leaves is also used in
liver problems and against anaemia.
The roots and bark are used to treat
malaria.
stem bark 49, 53, 54, 55,
56, 57 and 58
Antiplasmodial,
Lenta et al. [63]
Hypericaceae, Clusiceae
or Guttiferae
Garcinia Polyantha The plant has some anti-malarial
property. The yellow resinous sap
(latex) is used to make a dressing
for wounds.
root bark 59 This compound shows
anti-malarial activity by strong
chemosuppression of parasitic
growth, Lannang et al. [64]
Allanblackia
gabonensis
Used against infections like
dysentery, cold, and toothache.




activities against a range of
Gram-negative and Gram-positive
bacteria, Azebaze et al. [82]
Ntie-Kang et al. BMC Complementary and Alternative Medicine 2013, 13:147 Page 7 of 18
http://www.biomedcentral.com/1472-6882/13/147




Used to cure several diseases such
as stomach and skin aches. It is
also used as laxative for pregnant
women and as a general tonic.
The bark is used by traditional
healers to treat malaria.
seed shells 65, 66, 67
and 68
Anti-malarial, antioxidant,
Ngouela et al. [65]
Psorospermum
febrifugum
Plants of this genus are largely
used in the African folk medicine
as febrifugal, antidote against
poison and purgative. They are
also used as a remedy for the
treatment of leprosy, skin diseases
(such as dermatitis, scabies and
eczemas) and subcutaneous
wounds.
roots 69 Antimicrobial (bacteria and fungi),
Tsaffack et al. [83]
Pentadesma
butyracea
Different parts of the plant are
used in tropical African medicine
to treat fever, coughs, constipation,
bronchitis, and venereal diseases
and viral infections.
fruit pericarp 70 Erythrocyte susceptibility,
antiplasmodial, Lenta et al. [84]
Ixonanthaceae Irvingia gabonensis The stem bark decoction is used in
the treatment of gonorrhoea,
gastrointestinal or hepatic
disorders, as a purgative, as well
as a host of ailments. The decoction
of the root barks is also used to
treat diarrhoea and as mouth bath
in the dental neuralgias.
stem bark 49, 53, 71, 72,
73 and 74




use of the plant in the treatment
of the disease caused by this
agent, Kuete et al. [85]
stem bark 53
Hepatoprotective activity. This
crude extract and isolated
compound 53 might be useful for
the prevention of toxic-induced
and free radical-mediated liver
diseases, since it has been
suggested that compounds may
be used as prophylactic agents,





Crude extracts from root and stem
bark are used to treat boils, insect
bites, inflammatory affections like
pneumonia and asthma, sterility,
amenorrhea and menopausal
disorders.
root bark 75 and 76 Estrogenic activity,
Wanda et al. [45]
Erythrina
sigmoidea
Widely used in Cameroon to treat
syphilis, wounds of ulcers and
female sterility.
stem bark 77, 78 and 79 Antibacterial activity against
Staphylococcus aureus,
Kouam et al. [87-89]
Meliaceae Entandrophragma
angolense
Used as an anti-malarial or
antipyretic in traditional medicine.
stem bark 80 and 81 Antiplasmodial,
Bickii et al. [67]
Turraeanthus
africanus
Treatment of typhoid fever. seeds 82 Antisalmonellal activity
against Salmonella typhi,
S. paratyphi A and S. paratyphi B,
Djemgou et al. [90]
The species of this genus have
been used for the treatment of
cardiovascular disease, stomach
ache, rheumatism pains, and
asthma. The stem bark is used in
the treatment of intestinal worms.
seeds 82 Antimicrobial, Djemgou et al. [90]
The trunk bark and seeds of this
plant are boiled together with
Carica papaya leaves, the seeds of
Aframomum melegueta and lime
and used for treatment of malaria
and other fevers.
seeds 83, 84 and 85 Antiplasmodial activity,
Ngemenya et al. [91]
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Used to prepare remedies for
infectious diseases and is known
for its antibacterial and
antiplasmodial activities.
stem bark 86 Exhibited antimicrobial activity
against Proteus vulgaris,
Nchancho et al. [92]
Albizia
adianthifolia
Used traditionally to treat several
ailments, including infectious and
associated diseases.
stem bark 24 Antioxidant and antimicrobial
activities, Tamokou et al. [93]
Monimiaceae Glossocalyx
brevipes
The macerated leaves are added
to anti-fever preparations.
leaves 87, 88 and 89 Anti-malarial, Mbah et al. [66]
Moraceae Morus mesozygia Roots, stem and leaves are used
to treat syphilis, dermatitis,
rheumatism, asthenias, fever and
malaria.
stem bark 90, 91 and 92 Cytotoxic and anti-malarial,
Zelefack et al. [68]
Antiaris africana Bark extracts are used for the
treatment of chest pain, leaf
decoctions for the treatment of
syphilis, and the latex is a purgative
agent. It is also used in the
treatment of sore throat, leprosy
and cancer.
stem bark 93 Antioxidant and anticancer,
Kuete et al. [94]
Treculia obovoidea Traditionally used to treat skin
diseases, dental allergy, amoebic
dysentery and AIDS
twigs 94 Antimicrobial activity,
Kuete et al. [95]
Moraceae Artocarpus
communis
Treatment of cardiovascular diseases,
used as food; other parts of the
plants are traditionally used to
treat headache, infectious and
associated diseases such as
toothache, eye problems, ear
infections, herpes, enlarged spleen,
sprains, contusions, swelling, chest
pain and vomiting from heart
problems, boils, abscess, and
skin infections.
root 95 and 96 Antimicrobial activities,
Kuete et al. [96]
Dorstenia barteri Used in the treatment of malaria. twigs 97, 98, 99, 100,
101 and 102
Anti-malarial activity,
Ngameni et al. [69]
Ficus cordata Used against hyperaesthesia, ataxia,
muscle tremor, padding motions
and jaundice, which could be a
symptom of several related liver
diseases.
stem bark 11, 103, 104,
105 and 106
Hepatoprotective and
cytotoxic, Donfack et al. [97]
Myristicaceae Pycnanthus
angolensis
Treatment of stomach pain, chest
pain and rhinitis problems, malaria,
toothache, fungal skin infections,
chest pain, oral thrush, and worms;
some further claim a folkloric use
for the treatment of leprosy.
stem bark 107, 108
and 109
Antifungal activity,
Wabo et al. [98]
Olacaceae Coula edulis Treatment of stomach ache and
skin diseases.
stem bark 110 and 111 Antidermatophytic activity
against Microsporum audouinii
and Epidermophyton floccoseum,
Tamokou et al. [99]
Sapotaceae Baillonella
Toxisperma
Treatment of abscesses, infertility,
stomach troubles, convulsion,
rheumatism and malaria.
stem bark 49 and 112 Activity against Plasmodium
falciparum, Mbah et al. [70]
Verbenaceae Vitex cienkowskii Used in the treatment of many
disorders, including cardiovascular
disease.
stem bark 113 Vasorelaxant, antioxidant and
hypertensive effect, Dongmo
et al. [100]
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Used to treat fevers. seeds 114, 115
and 116
Anti-malarial,
Kenmogne et al. [71]
Reneilmia
cincinnata
Used to treat fevers and as a spice. fruits 117, 118
and 119
Anti-malarial,
Tchuendem et al. [72]
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http://www.biomedcentral.com/1472-6882/13/147and furocoumarins [51]. It was also noticed that 6,9-
dihydro-megastigmane-3-one (12) has been isolated from
the genus Treculia (both T. africana and T. Acuminata).
This compound may tentatively be considered as a
marker of the Treculia genus. Isobavachalcone (13),
previously isolated from several species of the genus
Dorstenia, can be used to establish intertribal relationship
between the two genera Treculia and Dorstenia [52].
Moreover, the isolation of compounds 8, 14 and 15 from
Dorstenia and Ficus species indicate that these com-
pounds could be chemotaxonomic markers for the
Dorstenia genus and confirms that the genera Dorstenia
and Ficus are closely related taxonomically [53]. Regar-
ding the Ochnaceae, the biflavonoid amentoflavone
(16) could be as well regarded as the taxonomic marker
of the genus Ouratea, ochnaflavone (17) used to identify
species of both Ouratea and Ochna, while lophirone A
(18) could be associated with almost all genera in the fam-
ily [54,55]. Meanwhile, the presence of the flavonoid
luteolin (19) in Lophira alata could be used to distinguish
between the two species L. alata and L. Lanceolata [56].
Among species of the Rutaceae family, the accumulation of
acridone alkaloids displays a common biogenetic trend in
the genus Citrus, and could be used to distinguish this
genus from the counterpart Afraegle [57]. Meanwhile,
within this same family, the unique presence of the
tetranortriterpenoids (20–23) within the genus Clausena,
could reveal that these compounds are of taxonomic inte-
rest [58]. Within the Zingiberaceae family labdane
diterpenes may represent a chemotaxonomic marker of the
genus Aframomum. However, A. arundinaceum is one of
the few species of Aframomum from which sesquiterpenoids
are reported [59,60].
Bioactivity versus ethnobotanical uses
Ethnobotany is the study of how modern and indigenous
societies view and use plants [61]. As previously mentioned,
medicinal plants from Cameroon have been used to
treat a number of ailments. In this study, our focus is on
those plants from which bioactive secondary metabolites
have been isolated, which validate their ethnobotanical
uses. Table 2 shows a summary of the results of biological
activities of the isolated compounds, which correlate with
the ethnobotanical uses of the plants (while the che-
mical structures of the bioactive metabolites are shown in
Figures 5, 6, 7 and 8). In each case, the significant uses
and corresponding bioactivities are in bold characters.The activities of the selected metabolites are anti-malarial,
estrogenic, antisalmonellal, hepatoprotective, antifungal,
antioxidant, antidermatophytic, vasorelaxant, anticancer,
antileishmanial, antimicrobial and α-glucosidase inhibition.
The antimalarials with significant antiparasitic activity,
which have been isolated from plants used in anti-malarial
or anti-fever preparations include: betulinic acid (49),
2,2’,5,6’-tetrahydroxybenzophenone (50), 5-hydroxy-3-
methoxyxanthone (51) and 3-hydroxy-5-methoxyxanthone
(52) [62]; bazouanthrone (54), ferruginin A (55), harunganin
(56), harunganol A (57) and harunganol B (58) [63];
isoxanthochymol (59), which exhibited an anti-malarial
activity against the NF54 strain with a 50% inhibitory
concentration (IC50) of 2.21 μM [64]; gaboxanthone (65),
symphonin (66), globuliferin (67) and guttiferone A (68)
[65]; garcinone E (70), with an IC50 of 0.20 μM, which was
isolated from Pentadesma butyracea, concurrently with
other potent anti-malarials pentadexanthone, cratoxylone
and α-mangostin [66]; the limonoid 7α-obacunyl acetate
(80) [67]; the homogentisic acid derivatives methyl 2-(1’β-
geranyl-5’β-hydroxy-2’-oxocyclohex-3’-enyl) acetate (87)
and 2-(1’β-geranyl-5’β-hydroxy-2’-oxocyclohex-3’-enyl)
acetic acid (88) and the alkaloid liriodenine (89) isolated
from Glossocalyx brevipes [66]; the flavonoids artocarpesin
(90), Kushenol E (91), and the arylbenzofuran derivative
mulberrofuran F (92) isolated from Morus mesozygia [68];
the chalcones bartericin A (97) and 4-hydroxylonchocarpin
(100) [69]; 3-O-betulinic acid p-coumarate (112) isolated
from Baillonella toxisperma, with an IC50 of 1.65 μM
[70]; the labdane 3-deoxyaulacocarpin A (115) from
Aframomum zambesiacum [71]; and the sesquiterpenoids
oplodiol (118), 5E,10(14)-germacradien-1β,4β-diol (119)
and 1(10)E,5E-germacradien-4α-ol (120) with respective
IC50 values of 4.17, 1.63 and 1.54 μM [72]. In all cases,
antiplasmodial activity was measured by inhibition of
the chloroquine-resistant W2 P. falciparum strain with
IC50 < 5 μM.
The isoflavonoids 3’,4’-dihydroxy-7-O-[(E)-3,7-dimethyl-
2,6-octadienyl]isoflavone (75) and Griffonianone C (76),
which have been isolated from Millettia griffoniana
(used traditionally to treat female sterility, amenorrhea and
menopausal disoders), both showed interesting estrogenic
activities, thus validating the ethnobotanical uses of the
plant [45]. Meanwhile, the anticancer properties of 3,3’-
dimethoxy-4’-O-β-D-xylopyronosylellagic acid (93) from
Antiaris africana (a plant traditionally used to treat
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Figure 5 Chemical structures of bioactive metabolites I. Compounds 24 to 52.
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Figure 6 Chemical structures of bioactive metabolites II. Compounds 53 to 79, 82 and 93.
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http://www.biomedcentral.com/1472-6882/13/147compound indicated a pronounced tumor reducing activity
(96.64%) in potato disk tumor induction assay and also
showed interesting inhibitory properties against humanDU-145 and hepatocarcinoma Hep G2 cells with > 70%
inhibition at 50 μg/mL [94]. At the same time, the cer-
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Figure 7 Chemical structures of bioactive metabolites III. Compounds 80, 81, and 83 to 106.
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Figure 8 Chemical structures of bioactive metabolites IV.
Compounds 107 to 119.
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acid from Vitex cienkowskii, thus validating the use of the
plant in the treatment of cardiovascular diseases [100].
The antidiabetic property of Terminalia superba has
been verified by the isolation of 3,4’-di-O-methylellagic
acid 3’-O-β-D-xylopyranoside (45) and 4’-O-galloy-3,3’-di-
O-methylellagic acid 4-O-β-D-xylopyrano-side (46), which
both exhibited good α-glucosidase inhibition [80], while
the antioxidant properties of the compounds isolated from
Symphonia globulifera could also be used to validate the
use of the plant in the preparation of tonics for pregnant
women [65].
Among the plants used in the treatment of diseases
related to the liver, the most promising are Ficus
cordata and Irvingia gabonensis, from which com-
pounds with hepatoprotective properties have been
isolated [86,97]. Among the isolated compounds, 3-
friedelanone (53) might be useful for the prevention
of toxin-induced and free radical-mediated liver dis-
eases [86].
Plants used for the treatment of microbial infections
have also been heavily explored. Compounds with
antisalmonellal activity have been isolated from plants
which have been traditionally used to treat typoid fever
(an infection principally caused by Salmonella typhi and
related baccili). The plant species include: Turraeanthus
africanus, from which 12,15-epoxylabda-8(17),12,14-trien-
16-acetate (82) has been isolated and was found to be the
only active principle, possessing the minimum inhibitory
concentration (MIC) and minimum bactericidal concen-
tration (MBC) values of respectively 25 μg/mL and
100 μg/mL against Salmonella typhi, S. paratyphi A and S.
paratyphi B [90]; and Cassia petersiana from which
stigmasterol-3-O-β-D-glucoside (35) was identified as the
active principle [77]. Several other plant species have
been investigated for their potential for antimicrobial
agents due to their uses in traditional medicine. The
isolated metabolites have been tested against a wide
range of Gram-positive bacteria, Gram-negative bacteria
and fungi. The most convincing studies for antifungal
plants were carried out by Ndom et al. [75], Ngounou et al.
[76], Dzoyem et al. [81], Tsaffack et al. [83], Wabo et al.
[98] and Tamokou et al. [99] on Senecio mannii, Ceiba
pentandra, Diospyros canaliculata, Psorospermum fe-
brifugum, Pycnanthus angolensis and Coula edulis
respectively. Besides, the diterpenoid hardwickiic acid (74),
which was isolated from Irvingia gabonensis (used in
the treatment of gonorrhoea, among other ailments)
was shown to be particularly active against Neisseria
gonorrhoeae in vitro with an IC50 of 4.26 μM [85].
Conclusions
In this paper, an attempt has been made to establish trends
towards a chemotaxonomic classification of medicinal
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document dispersed data on plants, whose ethnobotanical
uses have been validated by bioassay screening of the iso-
lated phytochmicals. The information contained herein
could serve as a starting point for further studies on Cam-
eroonian medicinal plants. This further demonstrates that
the Cameroon rainforest has a great potential for new drugs
and improved plant medicines [15,19]. However, plants
from a good number of families have never been investi-
gated phytochemically. These include, among others, the
Agavadeae, Amaranthaceae, Araceae, Aspidiaceae, Baming-
toniaceae, Basellaceae, Begoniaceae, Capparaceae, Carica-
ceae, Chenopodiaceae, Commelinaceae, Convolvulaceae,
Cuburbitaceae, Ericaceae, Icacinaceae, Lecydiaceae, Loran-
thaceae, Lythraceae, Malvaceae, Musaceae, Nyctginaceae
and Oxalicaceae, which have diverse uses in traditional
medicine [20]. Moreover, a majority of the plant species
studied have been harvested in the rainforests of the
Southern part of the country (our statistacs show that >
95% of the isolated metabolites were derived from plants
harvested in the North West, South West, Littoral and
Western plateau as well as the Centre, South and East
regions). However, on the basis of the fact that the
Northern parts of the country represent the semi-arid
and arid regions, the variations in soil composition and
climatic conditions could result in dramatic variations of
phytochemical compositions of the plant species and
should be subject to further investigation, since the local
populations in this part of the country are heavily
dependent on traditional herbal medicines for their pri-
mary health care. One species which needs to be ur-
gently subjected to phytochemical investigation is
Bridelia ferruginea, whose leaves, barks and fruits are
used for the treatment of dysentery, diabetes and as a
remedy for thrush (mycotic stomatitis) in children
[101,102], and as an antidote for snake bite [103]. In
addition, the root decoction is also used for the treat-
ment of gonorrhoea [104] and as an antidote for poi-
sons [103]. The ethnobotanical use of this plant has
been validated by in vitro activity of the leaf extracts
against Pseudomonas frutescens, Bacillus subtilis, Sta-
phylococcus aureus, Streptococcus faecalis, and Eche-
richia coli [103]. Another species that requires to be in-
vestigated is Piper guineense, whose antifungal proper-
ties have been verified by screening of the leaf extracts
[105]. Moreover, the phytochemical contents of 26 spe-
cies that are currently used for the treatment of hyper-
tension and cardiovascular problems in the Bafia tribal
people [27], could be further investigated with a view to
identifying potential lead compounds for the develop-
ment of drugs against cardiac problems, while those
used to treat intestinal disorders in Mbalmayo, Central
region [106], could also be examined for their anti-
microbial potential.Additional file
Additional file 1: Full list of consulted journals in constructing
CamMedNP.
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